Biopharmaceutical company Corcept Medical (NASDAQ: CORT) recently disclosed that the wholesale acquisition cost for a standard 28-day course of its novel endocrine therapy Lobivorli is $37,900.

老虎证券2026/03/25 19:06

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This pricing strategy provides clear economic parameters for medical payers to assess this breakthrough treatment for Cushing's syndrome. The company emphasized that this price reflects the significant efficacy and innovative value demonstrated by the therapy in clinical studies.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Biopharmaceutical company Corcept Medical (NASDAQ: CORT) recently disclosed that the wholesale acquisition cost for a standard 28-day course of its novel endocrine therapy Lobivorli is $37,900.

You may also like

Crypto prices